Publications by authors named "M Raderer"

Claim this Profile
C
Comparisons of treatment performance and therapy sequences in neuroendocrine neoplasms using progression-free survival ratios.
Philipp Melhorn, Elisabeth Kretschmer-Chott, Peter Mazal, Markus Raderer, Barbara Kiesewetter

Eur J Nucl Med Mol Imaging· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
K11.1 (hERG1)-centered macromolecular membrane complexes regulate proliferation in B cell lymphomas and constitute novel pharmacological targets.
Cesare Sala, Jessica Iorio, Claudia Duranti, Alberto Montalbano, Laura Clara Grandi, Markus Raderer

Pharmacol Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete remission of bronchus-associated lymphoid tissue lymphoma after antibiotic treatment for Tropheryma whipplei.
Teresa Antonia Kiener, Gregor Schweighofer-Zwink, Gundula Rendl, Jan Marco Kern, Lenka Baskova, Markus Raderer

Haematologica· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of Biomarkers in Cancer Patients Treated With Immune Checkpoint Inhibitor Therapy.
Christopher Mann, Ulrike Pailer, Andreas Spannbauer, Fardin Hamidi, Aliza Veronika Braser, Markus Raderer

JACC Adv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Availability and characteristics of clinical trials for neuroendocrine tumors: Is there an unmet need?
Philipp Melhorn, Amirhossein Sadeghi, Markus Raderer, Barbara Kiesewetter

Eur J Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis